Construction Kicks Off on Ohio State’s New Cancer Hospital
A new era of cancer care and research at The Ohio State University began June 18th when the University broke ground for ProjectONE, a $1 billion initiative that includes construction of a 17-story medical tower that will house a reimagined James Cancer Hospital and Solove Research Institute and an equally innovative critical care hospital.
Completion of the new 276-bed cancer hospital and 144-bed critical care hospital is slated for 2014.
The design of the tower will place cancer researchers near clinicians to promote their interaction and to expedite discovery and its tran-slation to patient care. It emphasizes the education of future healthcare professionals, particularly in “P4 Medicine”—health care that is predictive, preventive, personalized and participatory.
The largest construction initiative in Ohio State University history, ProjectONE will create 5,000 construction jobs over the next four years and at least 6,000 full-time positions at the University from 2008-15.
OSUCCC Director and James CEO Michael A. Caligiuri, MD, spoke at the June ceremony, noting that the groundbreaking was held nearly 20 years to the day that marked the opening of the present James Cancer Hospital in July 1990.
“We’re all here today because a generation of people before us was willing to invest in the future, to create the environment in which we now prosper,” Caligiuri said. “Now, it is our turn to build the future for the next generation.”
RIDERS REFLECT ON PELOTONIA 2010
Some 4,047 riders participated in the 2010 Pelotonia bicycling event held Aug. 20-22 to raise money for cancer research at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. Here are excerpts from a few of the notes ride organizers received after the event.
We were all lined up to go at the starting line at 7 a.m. There was much excitement as we headed out into the sunrise, and supporters rang cowbells and cheered for us. As we approached the outskirts of the city I really wondered what I had gotten myself into and if I ought to just give up! But right at that time another girl started riding next to me, and we got to talking. She was riding for her dad who had passed away. I thought about all those people who have struggled with their treatments and felt like they could not go on, and I just kept on peddling for them.
Every time along the way I wanted to quit, there was someone cheering on the roadside to spur me on, or another rider saying “You can do it!” (or good-naturedly teasing me about my pathetic cardiovascular conditioning). And I just kept thinking about all of you who have supported me, and about how cancer has touched you, and the people that you want to find a cure for.
I believe that research is leading us to a world where HOPE will be foremost in the minds of everyone who hears the words, “You have cancer.” Because the new treatments will be so successful, they will have no reason not to have hope. I believe that this ride, and the money that is going to the James Cancer Hospital and Solove Research Institute, is going to have a profound impact and will bring us closer to that world even sooner than we have dreamed.
I rode the 100+ mile route from Columbus to Athens. Last year at this time, I was participating in the Flavopiridol clinical trial. During the trial, I told my wife that if I was able to I’d like to ride in Pelotonia this year. After getting the message from Dr. Byrd on March 1st that I was “stable,” I registered for Pelotonia and put in over 1,000 miles on my bike between then and last weekend.
Riding into Athens late Saturday afternoon and making that final turn into the Ohio University campus was a dream come true. My sincere thanks to all who played a part in my treatment.
I want to share the story of a fellow rider who encouraged me to continue when the going got tough. At our 43-mile lunch stop, my [partner] and I noticed an elderly gentleman who was cycling as well. We thought he must have gone to the wrong lunch tent because it appeared that he was continuing on to do the 102-mile ride, which seemed impossible at his age. However, he was continuing on, and every time I wanted to give up, I thought of him. Not only did we see him at the 102-mile finish later that day, on Sunday we found out that he spent the night in Athens and rode the entire 180 miles, and that he is 80 years old! He even took a wrong turn and did a few extra miles on accident. He says it was the ride of his life for the love of his life – his wife of 57 years who is celebrating her 22nd year as a cancer survivor. Pretty inspiring stuff.
I rode for Grandma, Gary, Betty, Ruth, Anne, Sylvia, and all my friends, co-workers, patients and relatives who have fought cancer, and I learned that nothing is impossible – not even a cancer-free world!
For more information about Pelotonia, visit http://www.pelotonia.org.
If you have questions about Pelotonia, please e-mail firstname.lastname@example.org.
Revenue funds "Idea Grants" and student fellowships at Ohio State
Last year’s inaugural Pelotonia cycling tour attracted 2,265 riders and raised more than $4.5 million for cancer research at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC-James).
A portion of that revenue has been awarded as two-year Idea Grants to OSUCCC-James investigators, and as fellowships to promising undergraduate, medical, graduate and postgraduate researchers.
Idea Grants were awarded to 10 teams of OSUCCC-James research groups to pursue high-risk, high-reward studies.
“Pelotonia Idea Grants provide seed funding for ideas that can lead to critical preliminary data, new collaborations, and ultimately discovery – and that, in turn, can lead to breakthroughs in science, prevention and treatments, and to larger grants,” says Michael A. Caligiuri, MD, director of the OSUCCC and CEO of The James.
Idea grant applications were judged via a peer-review process that considered potential for discovery, publication, clinical trials, patents and leverage for subsequent funding from the National Cancer Institute.
Twenty-nine Pelotonia fellowships have been awarded to Ohio State undergraduates, one medical student and two postdoctoral researchers. The students will conduct cancer research in various laboratories at the OSUCCC-James during 2010-11. (The selection of graduate and additional postgraduate fellowships was under way at this writing.)
Pelotonia Undergraduate Fellowships were available to all Ohio State University undergraduate students in any field of study. Winning applications were selected by an 11-member committee based on applicant strengths and research potential, mentor qualifications, and relevance of the project to cancer research.
More than 4,000 riders and volunteers participated in this year’s Pelotonia event (see www.pelotonia.org). For more about the Pelotonia grant and fellowship awardees, see http://cancer.osu.edu/research/researcheducation/pelotoniafellowshipprogram/pages/index.aspx